Weight loss and maintenance is one key focus whilst the other is gastric retention (delay of digestion). These carbohydrate based technology approaches form long dwelling polysaccharide structures in the stomach when swallowed and thus provides a sensation of 'feeling full'; reducing the amount and frequency of food consumed supporting weight control/reduction. This approach also retains nutrients/drugs within the stomach longer and thus provides a controlled digestion/release opportunity.

The product matrices can be formulated in conjunction with different nutritional and therapeutic agents as required; having a very flexible format. Products can be used in dry (e.g. sachet formats added to water), in drinks or engineered into foods.


Resource 1 - Compositions and Uses Thereof

Resource 2 - A novel starch for the treatment of glycogen storage diseases

Resource 3 - Use of slow release starch (SRS) to treat hypoglycaemia in Type 1 diabetics

Resource 4 - Tolerance and nutritional therapy of dietary fibre from konjac glucomannan hydrolysates for patients with inflammatory bowel disease (IBD)

Resource 5 - Effect of short term administration of glucomannan hydrolysates on adult blood lipid parameters and glucose concentrations

Resource 6 - Beneficial health characteristics of native and hydrolysed konjac (Amorphophallus konjac) glucomannan

Resource 7 - Inhibition of the adhesion of Escherichia coli to human epithelial cells by carbohydrates

Resource 8 - Effect of composition and structure of native starch granules on their susceptibility to hydrolysis by amylase enzymes

Resource 9 - Effect of native starch granule size on susceptibility to amylase hydrolysis

Resource 10 - Heat and moisture modification of native starch granules on susceptibility to amylase hydrolysis

Resource 11 - Glucomannans and nutrition

What's new?

Clinical trial under development to assess how specific polysaccharides impact upon nutrient absorption.